thromboxanes has been researched along with Pulmonary Hypertension in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (52.27) | 18.7374 |
1990's | 13 (29.55) | 18.2507 |
2000's | 5 (11.36) | 29.6817 |
2010's | 2 (4.55) | 24.3611 |
2020's | 1 (2.27) | 2.80 |
Authors | Studies |
---|---|
Becker-Pelster, EM; Delbeck, M; Dietz, L; Hahn, MG; Hüser, J; Kopf, J; Kraemer, T; Marquardt, T; Mondritzki, T; Nagelschmitz, J; Nikkho, SM; Pires, PV; Sandner, P; Schuhmacher, J; Stasch, JP; Tinel, H; Truebel, HKF; Weimann, G; Wunder, F | 1 |
Ahsan, F; Alam, F; Blood, AB; Giri, PC; Hanson, SFL; Moretta, DT; Power, GG; Terry, MH; Wilson, SM | 1 |
Chelikani, P; Dakshinamurti, S; Hinton, M; Santhosh, KT; Sikarwar, AS | 1 |
Harada, M; Kaji, Y; Maruyama, T; Ohsaki, K; Shimoda, S | 1 |
Fike, CD; Kaplowitz, MR; Zhang, Y | 1 |
Flynn, JT; Gee, MH; Havill, AM; Perkowski, SZ | 1 |
Demling, RH; Flynn, J; Nerlich, M | 1 |
Lyrene, RK; Philips, JB | 1 |
Bauer, M; Bhakdi, S; Seeger, W | 1 |
Ali, M; Cooper, JD; McDonald, JW; Morgan, E; Townsend, ER | 1 |
Canham, EM; Heffner, JE; McMurtry, IF; Morris, HG; Repine, JE; Shoemaker, SA; Tate, RM | 1 |
Canham, EM; Heffner, JE; McMurtry, IF; Morris, HG; Patel, M; Repine, JE; Shoemaker, SA | 1 |
Kong, D; Peterson, MB; Watkins, WD; Wonders, TR; Zapol, WM | 1 |
Demling, RH; Holcroft, JW; Smith, ME | 1 |
Hüttemeier, PC; Peterson, MB; Watkins, WD; Zapol, WM | 1 |
Hüttemeier, PC; Kong, D; Peterson, MB; Watkins, WD | 1 |
Huttemeier, PC; Martin, EG; Peterson, MB; Watkins, WD; Zapol, WM | 1 |
Grimminger, F; Kramer, HJ; Mayer, K; Seeger, W; Stevens, J; Wahn, H; Walmrath, D | 1 |
Bischoff, P; Eisenmann, B; Epailly, E; Geny, B; Haberey, P; Mettauer, B; Muan, B; Piquard, F | 1 |
Baron, DA; Heffner, JE; Zamora, CA | 1 |
Brilli, RJ; Krafte-Jacobs, B; Moore, L; Passerini, D; Roselle, D; Salzman, AL; Smith, DJ; Szabó, C; Vromen, A | 1 |
Christman, BW | 1 |
Delong, P; Hubbard, CL; Huggins, E; McCall, C; O'Sullivan, MG | 1 |
Bailey, CL; Channick, RN; Rubin, LJ | 1 |
Blair, KS; Blum, MG; Chang, AC; Christman, BW; Collins, BJ; Parker, RE; Pierson, RN; Zorn, GL | 1 |
Barst, RJ | 1 |
Gray, BM; Li, JX; Lu, CY; Oliver, JR; Philips, JB | 1 |
Aziz, SM; Gillespie, MN; Horstman, SJ; Pauly, TH | 1 |
Loscalzo, J | 1 |
Bowie, EJ; Murray, MJ; Nuttall, GA | 1 |
Bhakdi, S; Eberspächer, B; Grimminger, F; Holland, IB; Hugo, F; Obernitz, R; Seeger, W; Suttorn, N; Thomas, M; Walmrath, D | 1 |
Hales, CA; Quinn, DA; Robinson, D | 1 |
Dahms, TE; Lonigro, AJ; Sprague, RS; Stephenson, AH | 1 |
Bhakdi, S; Neuhof, H; Seeger, W; Suttorp, N; Walter, H | 1 |
Aramburo, MJ; Hammerman, C; Hill, V | 1 |
McDonald, JW; Smallbone, BW; Taylor, NE | 1 |
Ganey, PE; Roth, RA | 2 |
Carvalho, AC; Langleben, D; Reid, LM | 1 |
McKenney, D | 1 |
Boddi, M; Castellani, S; Fanara, F; Gensini, GF; Neri Serneri, GG; Pezza, A; Prisco, D; Rogasi, PG; Rostagno, C | 1 |
Baranowski, RL; Cheung, AK; Wayman, AL | 1 |
Flynn, JT; Gee, MH; Perkowski, SZ; Tahamont, MV | 1 |
Barst, RJ; Ratner, SJ | 1 |
5 review(s) available for thromboxanes and Pulmonary Hypertension
Article | Year |
---|---|
Prostaglandins, related compounds, and the perinatal pulmonary circulation.
Topics: Animals; Animals, Newborn; Arachidonic Acids; Blood Pressure; Epoprostenol; Female; Fetus; Humans; Hydroxyeicosatetraenoic Acids; Hypertension, Pulmonary; Infant, Newborn; Lung; Persistent Fetal Circulation Syndrome; Pregnancy; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Pulmonary Circulation; Sheep; SRS-A; Thromboxanes; Vascular Resistance; Vasoconstriction | 1984 |
Lipid mediator dysregulation in primary pulmonary hypertension.
Topics: Animals; Eicosanoids; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Macrophage Activation; Prostaglandin D2; Pulmonary Artery; Thromboxanes | 1998 |
Medical therapy of pulmonary hypertension. An overview of treatment and goals.
Topics: Anticoagulants; Cardiotonic Agents; Diuretics; Humans; Hypertension, Pulmonary; Oxygen Inhalation Therapy; Thromboxanes; Vasoconstriction; Vasodilator Agents | 2001 |
Escherichia coli hemolysin causes thromboxane-mediated hypertension and vascular leakage in rabbit lungs.
Topics: Animals; Capillary Permeability; Cell Membrane; Escherichia coli; Hemolysin Proteins; Hypertension, Pulmonary; Lung; Rabbits; Thromboxanes; Vascular Resistance | 1989 |
Arachidonate cyclooxygenase metabolites as mediators of complement-initiated lung injury.
Topics: Arachidonic Acids; Blood Proteins; Complement Activation; Cyclooxygenase Inhibitors; Humans; Hypertension, Pulmonary; Hypoxia; Leukocyte Count; Leukocytes; Lung; Lung Injury; Lymph; Microcirculation; Prostaglandin-Endoperoxide Synthases; Thromboxanes | 1985 |
1 trial(s) available for thromboxanes and Pulmonary Hypertension
Article | Year |
---|---|
Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Topics: Albumins; Animals; Anti-Inflammatory Agents; Blood Gas Analysis; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Diastole; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echocardiography; Exercise Test; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Pulmonary Circulation; Swine; Systole; Thromboxanes | 1993 |
38 other study(ies) available for thromboxanes and Pulmonary Hypertension
Article | Year |
---|---|
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.
Topics: Acetylcholine; Animals; Guanylate Cyclase; Hypertension, Pulmonary; Nitric Oxide; Rats; Soluble Guanylyl Cyclase; Swine; Swine, Miniature; Thromboxanes; Vasodilator Agents | 2022 |
Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Inhalation; Aerosols; Animals; Animals, Newborn; Antihypertensive Agents; Arterial Pressure; Cardiac Output; Disease Models, Animal; Female; Heart Rate; Hypertension, Pulmonary; Infusions, Intravenous; Male; Protein Kinase Inhibitors; Pulmonary Artery; rho-Associated Kinases; Sheep, Domestic; Thromboxanes; Vascular Resistance; Vasodilator Agents | 2018 |
Palmitoylation of Gαq determines its association with the thromboxane receptor in hypoxic pulmonary hypertension.
Topics: Animals; Animals, Newborn; Calcium; Cells, Cultured; Cysteine; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Hypertension, Pulmonary; Hypoxia; Lipoylation; Muscle Cells; Prostaglandins; Pulmonary Artery; Receptors, Thromboxane; Swine; Thromboxanes; Vasoconstriction | 2014 |
Thromboxane-dependent portopulmonary hypertension.
Topics: Disease Progression; Electrocardiography; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Middle Aged; Thromboxane A2; Thromboxane B2; Thromboxanes | 2005 |
Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets.
Topics: Animals; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Pulmonary Circulation; Pyridines; Swine; Thromboxanes | 2005 |
Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation.
Topics: Animals; Capillary Permeability; Chemotaxis, Leukocyte; Complement Activation; Endothelium; Hypertension, Pulmonary; Hypoxia; Ibuprofen; Lung Diseases; Meclofenamic Acid; Models, Biological; Pulmonary Circulation; Sheep; Superoxides; Thromboxanes | 1983 |
Effect of thermal injury on endotoxin-induced lung injury.
Topics: Animals; Burns; Endotoxins; Escherichia coli Infections; Fistula; Glucuronidase; Hypertension, Pulmonary; Hypoxia; Lung Diseases; Lymph; Sheep; Thromboxane B2; Thromboxanes | 1983 |
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bacterial Toxins; Blood Pressure; Calcimycin; Calcium; Calcium Channel Blockers; Calmodulin; Gallic Acid; Hemolysin Proteins; Hypertension, Pulmonary; In Vitro Techniques; Indomethacin; Lung; Prostaglandins; Pulmonary Artery; Rabbits; Sulfonamides; Thromboxanes; Trifluoperazine | 1984 |
Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Complement Activation; Female; Hypertension, Pulmonary; In Vitro Techniques; Leukocytes; Lung; Male; Pulmonary Artery; Sheep; Thrombocytopenia; Thromboxane B2; Thromboxanes | 1983 |
Staphylococcus aureus and human platelets cause pulmonary hypertension and thromboxane generation in isolated saline-perfused rabbit lungs.
Topics: Animals; Blood Platelets; Blood Pressure; Hypertension, Pulmonary; In Vitro Techniques; Lung; Platelet Count; Pulmonary Artery; Rabbits; Staphylococcus aureus; Thromboxanes | 1984 |
Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2.
Topics: Albumins; Animals; Blood Platelets; Hypertension, Pulmonary; Lung; Neutrophils; Platelet Activating Factor; Pulmonary Edema; Rabbits; Thromboxane A2; Thromboxanes | 1983 |
Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass.
Topics: Animals; Cardiopulmonary Bypass; Epoprostenol; Hypertension, Pulmonary; Leukocyte Count; Platelet Count; Prostaglandins; Prostaglandins F; Radioimmunoassay; Sheep; Thromboxane B2; Thromboxanes | 1980 |
Prostaglandin E1 and prostacyclin infusion decrease thromboxane production in endotoxin-induced lung injury.
Topics: Animals; Endotoxins; Epoprostenol; Escherichia coli; Female; Fistula; Hypertension, Pulmonary; Lung; Prostaglandins; Prostaglandins F; Sheep; Thromboxane A2; Thromboxanes | 1982 |
Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep.
Topics: Animals; Dinoprost; Endotoxins; Escherichia coli; Hemodynamics; Hypertension, Pulmonary; Leukopenia; Lung; Nitrogen Mustard Compounds; Prostaglandins F; Pulmonary Circulation; Sheep; Thromboxane B2; Thromboxanes | 1982 |
Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Endotoxins; Escherichia coli; Female; Hypertension, Pulmonary; Imidazoles; Lymph; Oxidoreductases; Prostaglandins F; Sheep; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1982 |
Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Dinoprost; Epoprostenol; Hypertension, Pulmonary; Indomethacin; Prostaglandins F; Sheep; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors; Vascular Resistance | 1982 |
Differential influence of arachidonic vs. eicosapentaenoic acid on experimental pulmonary hypertension.
Topics: Animals; Arachidonic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Escherichia coli; Female; Hemolysin Proteins; Hypertension, Pulmonary; Male; Potassium; Pulmonary Artery; Pulmonary Wedge Pressure; Rabbits; Thromboxane B2; Thromboxanes | 1995 |
Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hydrazines; Hypertension, Pulmonary; In Vitro Techniques; Ischemia; Lung; Organ Size; Pulmonary Circulation; Pulmonary Edema; Rabbits; Radioimmunoassay; Receptors, Thromboxane; Reperfusion Injury; Thromboxane A2; Thromboxane B2; Thromboxanes; Vasoconstriction | 1993 |
Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension.
Topics: Amino Acids, Diamino; Animals; Antihypertensive Agents; Blood Gas Analysis; Hemodynamics; Hypertension, Pulmonary; Intubation, Intratracheal; Male; Nitric Oxide; Nitroprusside; Swine; Thromboxanes; Vascular Resistance; Vasodilator Agents | 1997 |
Bacterial lipopolysaccharide induction of the prostaglandin G/H synthase 2 gene causes thromboxane-dependent pulmonary hypertension in rabbits.
Topics: Animals; Arachidonic Acid; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Dactinomycin; Drug Interactions; Enzyme Induction; Female; Hypertension, Pulmonary; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rabbits; Thromboxanes | 1999 |
A new era in the treatment of primary pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Bosentan; Epoprostenol; Female; Genetic Therapy; Humans; Hypertension, Pulmonary; Nitric Oxide; Sulfonamides; Thromboxanes; Vasodilator Agents | 2001 |
Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection.
Topics: Acute Disease; Animals; Capillary Permeability; Graft Rejection; Humans; Hypertension, Pulmonary; Inflammation Mediators; Lung; Lung Transplantation; Oxygen Consumption; Pneumonia; Pulmonary Circulation; Swine; Thromboxanes; Vascular Resistance | 2001 |
Delayed thromboxane synthesis inhibition, but not cholinergic blockade, reverses group B streptococcus-induced pulmonary hypertension.
Topics: Animals; Blood Gas Analysis; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypertension, Pulmonary; Imidazoles; Parasympatholytics; Pulmonary Circulation; Solanaceous Alkaloids; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vasodilator Agents | 1992 |
Impact of prostaglandin and thromboxane synthesis blockade on disposition of group B streptococcus in lung and liver of intact piglet.
Topics: Animals; Free Radicals; Hypertension, Pulmonary; Indomethacin; Liver; Lung; Methacrylates; Prostaglandins; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxanes | 1992 |
Endothelial dysfunction in pulmonary hypertension.
Topics: Calcium Channel Blockers; Endothelium, Vascular; Epoprostenol; Humans; Hypertension, Pulmonary; Thromboxanes | 1992 |
Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
Topics: Animals; Bleeding Time; Blood Coagulation; Carbazoles; Hemodynamics; Heparin; Hypertension, Pulmonary; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Protamines; Receptors, Prostaglandin; Receptors, Thromboxane; Swine; Thromboxanes | 1991 |
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Capillary Permeability; Epoprostenol; Escherichia coli; Female; Hemolysin Proteins; Hypertension, Pulmonary; In Vitro Techniques; L-Lactate Dehydrogenase; Lung; Male; Neutrophils; Perfusion; Potassium; Pulmonary Artery; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Respiratory Insufficiency; Sulfonamides; Thromboxane B2; Thromboxanes | 1991 |
Intravenous injection of propylene glycol causes pulmonary hypertension in sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Cardiac Output; Hypertension, Pulmonary; Indomethacin; Injections, Intravenous; Lymph; Propylene Glycol; Propylene Glycols; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Wedge Pressure; Sheep; Thromboxanes; Vascular Resistance | 1990 |
Thromboxane does not mediate pulmonary hypertension in phorbol ester-induced acute lung injury in dogs.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Dogs; Hypertension, Pulmonary; Lung; Lung Injury; Male; Methacrylates; Pulmonary Artery; Tetradecanoylphorbol Acetate; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes; Vascular Resistance | 1990 |
Intravenous lipids in newborn lungs: thromboxane-mediated effects.
Topics: Animals; Animals, Newborn; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Fat Emulsions, Intravenous; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Hypertension, Pulmonary; Lung; Oxygen Consumption; Pulmonary Artery; Swine; Thromboxane B2; Thromboxanes; Vascular Resistance; Vasodilation | 1989 |
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan | 1987 |
Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
Topics: Animals; Cyclooxygenase Inhibitors; Dibenzothiepins; Hypertension, Pulmonary; Ibuprofen; Imidazoles; Male; Monocrotaline; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Pyrrolizidine Alkaloids; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase; Thromboxanes | 1987 |
The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension.
Topics: Animals; Blood Platelets; Hypertension, Pulmonary; Imidazoles; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thromboxanes | 1986 |
Pulmonary hypertensive disorders and the arachidonic acid metabolites.
Topics: Adult; Animals; Arachidonic Acid; Arachidonic Acids; Child; Epoprostenol; Humans; Hypertension, Pulmonary; Infant, Newborn; Persistent Fetal Circulation Syndrome; Respiratory Distress Syndrome; SRS-A; Thromboxanes | 1988 |
Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Topics: beta-Thromboglobulin; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |
5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Topics: Animals; Blood Platelets; Hypertension, Pulmonary; Male; Monocrotaline; Platelet Aggregation; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Serotonin; Thromboxane B2; Thromboxanes; Time Factors | 1987 |
The role of thromboxane in cuprophan-induced pulmonary hypertension.
Topics: Animals; Cellulose; Female; Hypertension, Pulmonary; Male; Methacrylates; Swine; Thromboxanes; Zymosan | 1987 |
Sarcoidosis and reactive pulmonary hypertension.
Topics: Adult; Arterial Occlusive Diseases; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung; Pulmonary Circulation; Sarcoidosis; Thromboxanes | 1985 |